Cancer Type: Malignant Hematology
Study Type: Treatment
Phase: Phase I
Principal Investigator: Saeed, Hayder
A Phase I Study of Duvelisib in Combination with CC-486 in Lymphoid Malignancy
The purpose of the study is to find a safe dose and to evaluate the safety and tolerability of the drug CC-486, in combination with duvelisib.
1. To evaluate the safety and dose limiting toxicity of the combination of PI3K inhibitor (Duvelisib) with hypomethylating agent (CC-486) in patients with lymphoid malignancy; 2. To evaluate the overall response rate to the treatment with combination therapy; 3. To evaluate the disease control rate of the combination; 4. To evaluate the progression free survival and overall survival in patients treated with the combination therapy. Exploratory Objectives: 1. To evaluate the changes in different T cells subpopulation in response to PI3K inhibition and hypomethylation 2. To evaluate the changes in pAKT in response to single agent Duvelisib in comparison to combination Duvelisib and CC-486
CC-486 (Azacitidine (Oral)); Duvelisib ()
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
Back to top
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub
A secure website for patients to access their medical care at Moffitt.
An online resource for referring physicians and their staff.
For Moffitt faculty & staff members to access MoffittNet applications.
Our patient services specialists can assist you with scheduling an appointment, questions about medical records, insurance, billing and more.
Patient Appointment Center Hours: 7 a.m. to 7 p.m. Monday - Friday; 8 a.m. to noon Saturday